Kidney Int 1998;54:775784
[8] Novo Nordisk announced late at the 2025 European Association for the Study of Diabetes (EASD) annual meeting that in the REDEFINE 1 study, [9] cagrilintide provided clinically significant weight loss, with a mean reduction in body weight of 11.8% compared to 2.3% with placebo after 68 weeks, considering adherence of all participants to treatment
For hydrophobic peptides, a 50% aqueous acetic acid solution can be helpful
In this blog, we will discuss what alpha arbutin is, how it works, its sources, and most importantly, answer the question of whether it can be used with niacinamide
The Interplay Between Vitamin D and Glutathione Research has shown a fascinating connection between vitamin D and glutathione levels
If cortisol dysregulation or anxiety is the primary sleep disruptor, Selank may be the first-line intervention